From subjects to relations: Bioethics and the articulation of postcolonial politics in the Cambodia Pre-Exposure Prophylaxis trial

Abstract

Controversies about global clinical trials, particularly HIV trials, tend to be framed in terms of ethics. In this article, I explore debates about ethics in the Cambodia Pre-Exposure Prophylaxis trial, which was designed to test the safety and efficacy of tenofovir as a prevention for HIV infection. Bringing together studies of public participation in science with studies of bioethics, I show how activists around the Cambodian Pre-Exposure Prophylaxis trial circulated and provoked debates about standards of research ethics, as opposed to research methodology. This postcolonial bioethics was configured through the circulation of and debate about ethics guidelines, and historically and culturally specific relations of vulnerability and responsibility between foreigners and Cambodians and between Cambodian leaders and Cambodian subjects. I argue that this shift in the object of ethical concern, from the experimental human subject to the relation between subjects and researchers, illustrates how a postcolonial field of articulation reformulates classical bioethics.

Keywords

activism Cambodia controversy HIV prevention trials postcolonial bioethics

Get full access to this article

View all access options for this article.

References

Abraham

(2013) Clashing cultures of science. Postcolonial Studies 16(4): 406–408.

ACT-UP Paris (2004) Tenofovir: Inethical [sic] trial. Available at: http://www.actupparis.org/article1734.html (accessed 17 June 2005).

(2006) Indigenous politics, public health and the Cambodian colonial state. South East Asia Research 14(1): 33–86.

Benatar

(2002) Reflections and recommendations on research ethics in developing countries. Social Science and Medicine 54(7): 1131–1141.

Bhutta

(2002) Ethics in international health research: A perspective from the developing world. Bulletin of the World Health Organization 80(2): 114–120.

Bonn

(2005) Tenofovir: A pill to prevent HIV? The Lancet Infectious Diseases 5(2): 78.

Bourdier

(2005) Shadowing the facts: The rise and collapse of a controversial trial in Cambodia. HIV Australia 5(1): 25.

Bourdier

(2006) Policies and politics underlying the path for universal access to treatment against AIDS in Cambodia. Centre for East and South-East Asian Studies Working Paper no. 18. Lund: Lund University.

Bourdier

Bureau

(2010) Société civile et gouvernement en temps de sida au Cambodge. Moussons 15: 195–200.

10.

Brives

(2013) Identifying ontologies in a clinical trial. Social Studies of Science 43(3): 397–416.

11.

Brodwin

(2001) Pluralism and politics in global bioethics education. Annals of Behavioral Science and Medical Education 7(2): 80–86.

12.

Cha

(2006) AIDS drug trial turned away: Protests by prostitutes in Cambodia ended tenofovir testing. The Washington Post, 23 May, p. A10, A14.

13.

Chheng

(2002) Bioethics activities in Cambodia. Mekong Malaria Forum 10: 136.

14.

Collins

Evans

(2007) Rethinking Expertise. Chicago, IL: University of Chicago Press.

15.

Collins

(2004) Sex workers leery about HIV trial. The Cambodia Daily, 30 March. Available at: https://www.cambodiadaily.com/archives/sex-workers-leery-about-hiv-trial-39659/ (accessed on 17 February 2016).

16.

Collins

Kuch

(2004) Prostitute union to boycott AIDS drug trial. The Cambodia Daily, 16 June, pp. 1, 13.

17.

Coopmans

Button

(2014) Eyeballing expertise. Social Studies of Science 44(5): 758–785.

18.

Coren

(2003) AIDS drug trial gets green light from ethics board. Phnom Penh Post, 4 July, p. 5.

19.

Council for International Organizations of Medical Sciences (CIOMS) (2002) International ethical guidelines for biomedical research involving human subjects. Available at: http://www.cioms.ch/images/stories/CIOMS/guidelines/guidelines_nov_2002_blurb.htm (accessed 23 October 2013).

20.

Crane

(2010) Adverse events and placebo effects: African scientists, HIV, and ethics in the global health sciences. Social Studies of Science 40(6): 843–870.

21.

Doyle

Kuch

(2004) The slippery ethics of third world drug trials. The Cambodia Daily, 7 May, pp. 1–2. Available at: https://www.cambodiadaily.com/archives/the-slippery-ethics-of-third-world-drug-trials-40555/ (accessed 17 February 2016).

22.

Edwards

(2007) Cambodge: The Cultivation of a Nation, 1860–1945. Honolulu, HI: University of Hawaii Press.

23.

Edwards

(2008) The moral geology of the present: Structuring morality, menace and merit. In: Kent

Chandler

(eds) People of Virtue: Reconfiguring Religion, Power and Moral Order in Cambodia Today. Copenhagen: NIAS Press, pp. 213–237.

24.

Emanuel

Wendler

Killen

Grady

. (2004) What makes clinical research in developing countries ethical? The benchmarks of ethical research. Journal of Infectious Diseases 189(5): 930–937.

25.

Epstein

(1996) Impure Science: AIDS Activism and the Politics of Knowledge. Berkeley, CA: University of California Press.

26.

Fairhead

Leach

Small

(2006) Where techno-science meets poverty: Medical research and the economy of blood in the Gambia, West Africa. Social Science and Medicine 63(4): 1109–1120.

27.

Farmer

(2002) Can transnational research be ethical in the developing world? The Lancet 360(9342): 1266.

28.

Forbes

Mudaliar

(2009) Preventing Prevention Trial Failures: A Case Study and Lessons for Future Trials from the 2004 Tenofovir Trial in Cambodia. Washington, DC: Global Campaign for Microbicides at PATH.

29.

Ford

(2011) Treatment as prevention: We urgently need policy guidance. In: PLOS Speaking of Medicine Community Blog, 22 July. Available at: http://blogs.plos.org/speakingofmedicine/2011/07/22/treatment-as-prevention-we-urgently-need-policy-guidance/ (accessed 17 Feburary 2016).

30.

Gambian Government/Medical Research Council Joint Ethical Committee (1998) Ethical issues facing medical research in developing countries. The Lancet 351(9098): 286–287.

31.

Geissler

(2013) Public secrets in public health: Knowing not to know while making scientific knowledge. American Ethnologist 40(1): 13–34.

32.

Geissler

Pool

(2006) Popular concerns about medical research projects in Sub-Saharan Africa – A critical voice in debates about medical research ethics. Tropical Medicine and International Health 11(7): 975–982.

33.

Grant

Buchbinder

Cates

Jr . (2005) Promote HIV chemoprophylaxis research, don’t prevent it. Science 309(5744): 2170–2171.

34.

Halima

Collins

(2005) Stakeholder consultation to address issues related to Tenofovir prophylactic research. IAPAC Monthly 11(6): 166–169.

35.

Hammer

Lundstrom

(2006) Trials of Tenofovir: Mediating ethics in third-world research. Santa Clara University Legal Studies Research Paper no. 4; Sydney Law School Research Paper no. 9; Wayne State University Law School Research Paper no. 07-42. Available at: http://ssrn.com/abstract=1059161 (accessed 27 June 2013).

36.

Herrera

(2004) Growing pains in AIDS drug development. Nature Biotechnology 22(10): 1194.

37.

Hill

(2004) Ethics and health systems research in ‘post’-conflict situations. Developing World Bioethics 4(2): 139–153.

38.

Hoad

(2005) Thabo Mbeki’s AIDS blues: The intellectual, the archive, and the pandemic. Public Culture 17(1): 101–127.

39.

Kenworthy

Bulled

(2013) From modeling to morals: Imaging the future of HIV PrEP in Lesotho. Developing World Bioethics 13(2): 70–78.

40.

Kerr

Cunningham-Burley

Tutton

(2007) Shifting subject positions: Experts and lay people in public dialogue. Social Studies of Science 37(3): 385–411.

41.

Kuch

Collins

(2004) Researchers threaten to bypass sex union. The Cambodia Daily, 2 April, p. 13.

42.

Ledgerwood

(2003) Global concepts and local meaning: Human rights and Buddhism in Cambodia. Journal of Human Rights 2(4): 531–549.

43.

Bayer

(2003) Establishing ethical trials for treatment and prevention of AIDS in developing countries. British Medical Journal 327(7410): 337–339.

44.

Loff

Jenkins

Ditmore

Overs

Barbero

(2005) Unethical clinical trials in Thailand: A community response. The Lancet 365(9471): 1618–1619.

45.

Lurie

Greco

(2005) US exceptionalism comes to research ethics. The Lancet 365(9465): 1117–1119.

46.

McGoey

Reiss

Wahlberg

(2011) The global health complex. BioSocieties 6(1): 1–9.

47.

MacQueen

Shapiro

Karim

Sugarman

. (2004) Ethical challenges in international HIV prevention research. Accountability in Research 11(1): 49–61.

48.

Mills

Singh

Orbinski

Warren

Upshur

. (2005) Designing research in vulnerable populations: Lessons from HIV prevention trials that stopped early. British Medical Journal 331(7529): 1403–1406.

49.

Mol

(2002) The Body Multiple: Ontology in Medical Practice. Durham, NC: Duke University Press.

50.

Molyneaux

Geissler

(2008) Ethics and the ethnography of medical research in Africa. Social Science and Medicine 67(5): 685–695.

51.

Montgomery

(2012) Making prevention public: The co-production of gender and technology in HIV prevention research. Social Studies of Science 42(6): 922–944.

52.

Morsy

(1998) Not only women: Science as resistance in open door Egypt. In: Lock

Kaufert

(eds) Pragmatic Women and Body Politics. Cambridge: Cambridge University Press, pp. 77–97.

53.

National Bioethics Advisory Commission (NBAC) (2001) Ethical and policy issues in international research: Clinical trials in developing countries. Available at: http://bioethics.georgetown.edu/nbac/pubs.html (accessed 23 October 2013).

54.

Nguyen

V-K

(2005) Antiretroviral globalism, biopolitics, and therapeutic citizenship. In: Ong

Collier

(eds) Global Assemblages: Technology, Politics, and Ethics as Anthropological Problems. Malden, MA: Blackwell, pp. 124–144.

55.

Nuffield Council on Bioethics (2002) The ethics of research related to health care in developing countries. Available at: http://www.nuffieldbioethics.org/research-developing-countries (accessed 23 October 2013).

56.

Page-Shafer

Saphonn

Sun

Vun

Cooper

Kaldor

. (2005) HIV prevention research in a resource-limited setting: The experience of planning a trial in Cambodia. The Lancet 366(9495): 1499–1503.

57.

Parker

Bull

(2009) Ethics in collaborative global health research networks. Clinical Ethics 4(4): 165–168.

58.

Patton

Kim

(2012) The cost of science: Knowledge and ethics in HIV pre-exposure prophylaxis trials. Journal of Bioethical Inquiry 9(3): 295–310.

59.

Petryna

(2005) Ethical variability: Drug development and globalizing clinical trials. American Ethnologist 32(2): 183–197.

60.

Petryna

(2009) When Experiments Travel: Clinical Trials and the Global Search for Human Subjects. Princeton, NJ: Princeton University Press.

61.

Purthill

Yun

(2004) Hun Sen: Don’t test drugs on Cambodians. The Cambodia Daily, 4 August. Available at: https://www.cambodiadaily.com/archives/hun-sen-dont-test-drugs-on-cambodians-42117/

62.

Rabinow

(2002) Midst anthropology’s problems. Cultural Anthropology 17(2): 135–149.

63.

Redfield

(2013) Commentary: Eyes wide shut in transnational science and aid. American Ethnologist 40(1): 35–37.

64.

Rennie

Sugarman

the HPTN Ethics Working Group (2009) HIV prevention trials network: Ethics guidance for research, 10 June. Available at: http://www.hptn.org/web%20documents/EWG/HPTNEthicsGuidance020310.pdf (accessed 17 February 2016).

65.

Reubi

(2010) The will to modernize: A genealogy of biomedical research ethics in Singapore. International Political Sociology 4(2): 142–158.

66.

Rith

(2004) Sex workers stand firm on Bill Gates drug trial. Phnom Penh Post, 18 June, p. 6.

67.

Rosengarten

Michael

(2009) The performative function of expectations in translating treatment to prevention: The case of HIV pre-exposure prophylaxis, or PrEP. Social Science and Medicine 69(7): 1049–1055.

68.

Rottenburg

(2009) Social and public experiments and new figurations of science and politics in postcolonial Africa. Postcolonial Studies 12(4): 423–440.

69.

Roy

(2011) Postcolonial urbanism: Speed, hysteria, mass dreams. In: Roy

Ong

(eds) Worlding Cities: Asian Experiments and the Art of Being Global. Malden, MA: Wiley-Blackwell, pp. 307–335.

70.

Said

(2003) Orientalism. 25th Anniversary edn. New York: Vintage Books.

71.

Sandy

(2013) International agendas and sex worker rights in Cambodia. In: Ford

(ed.) Social Activism in Southeast Asia. London: Routledge, pp. 154–169.

72.

Saphonn

Sopheab

. (2004) Current HIV/AIDS/STI epidemic: Intervention programs in Cambodia, 1993–2003. AIDS Education and Prevention 16(3 Suppl. A): 64–77.

73.

Saray

(2007) Cambodia. In: Forum for Ethical Review Committees in Asia & the Western Pacific (FERCAP) international conference on developing quality systems in health research: Towards better human subject protection, Udon Thani, Thailand, 28–30 November. pp. 58–72.

74.

Sleeboom-Faulkner

(2013) Competitive adaptation: Biobanking and bioethical governance in China Medical City. East Asian Science, Technology and Society: An International Journal 7(1): 125–143.

75.

Sunder Rajan

(2010) The experimental machinery of global clinical trials: Case studies from India. In: Ong

Chen

(eds) Asian Biotech: Ethics and Communities of Fate. Durham, NC: Duke University Press, pp. 55–80.

76.

Tangwa

(2004) Between universalism and relativism: A conceptual exploration of problems in formulating and applying international biomedical ethical guidelines. Journal of Medical Ethics 30(1): 63–67.

77.

Thompson

(1993) Oh Cambodia! Poems from the border. New Literary History 24(3): 519–544.

78.

Ukpong

Peterson

(2009) Analyzing the events. In: Ukpong

Peterson

(eds) Oral Tenofovir Controversy II – Voices from the Field: A Series of Reports on the Oral Tenofovir Trials from the Perspectives of Active Community Voices in Cambodia, Cameroon, Nigeria, Thailand and Malawi. Lagos: New HIV Vaccines and Microbicides Study, pp. 44–46. Available at: http://www.nhvmas-ng.org/publication/TDF2.pdf

79.

(2015) From the Land of Shadows: War, Revolution, and the Making of the Cambodian Diaspora. New York: New York University Press.

80.

UNAIDS (2007) Ethical Considerations in Biomedical HIV Prevention Trials. Geneva: Joint United Nations Programme of HIV/AIDS.

81.

UNAIDS/AVAC (2007) Good Participatory Practice Guidelines in Biomedical HIV Prevention Trials. Geneva: Joint United Nations Programme of HIV/AIDS and AIDS Vaccine Advocacy Coalition.

82.

Vachon

(2002) New committee scrutinizes medical research. The Cambodia Daily, 19 August. Available at: http://www.cambodiadaily.com/archive/new-committee-scrutinizes-medical-research-34065/ (accessed 13 November 2013).

83.

Vachon

(2010) Revolutionary medicine. The Cambodia Daily, 24–25 April, p. 7.

84.

Vink

(2013) Quest for Land. iPad application. Available at: https://itunes.apple.com/us/app/quest-for-land/id520997749?mt=8 (accessed 17 February 2016).

85.

Watt

(2004) Sex workers threaten to block Bill Gates HIV Study. Phnom Penh Post, 26 March, p. 4.

86.

Women’s Network for Unity (WNU) (2004) Background to WNU press conference on tenofovir trials in Cambodia, 29 March–8 April. Unethical AIDS_ASIA/message/2/press conference on tenofovir trials in Cambodia, 29 March Available at: www.womynsagenda.org (accessed 7 April 2005).

87.

Women’s Network for Unity (WNU) (2005a) Letter to Samdech Hun Sen, 4 March. Available at: http://health.groups.yahoo.com/group/AIDS_ASIA/message/270 (accessed 6 March 2005).

88.

Women’s Network for Unity (WNU) (2005b) Sex workers have rights in drug trials. Pamphlet.

89.

Women’s Network for Unity (WNU) (2005c) WNU guide to collaborating on ethical drug trials. Available at: www.womynsagenda.org (accessed 17 June 2005).

90.

Womyn’s Agenda for Change (WAC) (2004) Gender and neo-liberal economic policies. Available at: www.womynsagenda.org (accessed 8 June 2005).

91.

Womyn’s Agenda for Change (WAC) (2005a) Unethical tenofovir trial: Cambodian sex worker’s concerns. Available at: https://groups.yahoo.com/neo/groups/AIDS_ASIA/conversations/messages/278 (accessed 17 June 2005).

92.

Womyn’s Agenda for Change (WAC) (2005b) Workshop on ethics of clinical trials in Cambodia. Workshop Announcement. Received from [AIDS-ASIA] eForum, 26 February. Available at: http://health.groups.yahoo.com/group/AIDS_ASIA/message/266 (accessed 17 February 2016).

93.

World Medical Association (2013) Declaration of Helsinki: Ethical principles for medical research involving human subjects. Available at: http://www.wma.net/en/30publications/10policies/b3/index.html (accessed 23 October 2013).

94.

Yin

(2004) Tenofovir experiment was stopped. Rasmei Kampuchea, 14 August.